These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17696817)

  • 21. Human tissue-engineered blood vessels for adult arterial revascularization.
    L'Heureux N; Dusserre N; Konig G; Victor B; Keire P; Wight TN; Chronos NA; Kyles AE; Gregory CR; Hoyt G; Robbins RC; McAllister TN
    Nat Med; 2006 Mar; 12(3):361-5. PubMed ID: 16491087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decellularized vein as a potential scaffold for vascular tissue engineering.
    Schaner PJ; Martin ND; Tulenko TN; Shapiro IM; Tarola NA; Leichter RF; Carabasi RA; Dimuzio PJ
    J Vasc Surg; 2004 Jul; 40(1):146-53. PubMed ID: 15218475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels.
    Chan-Park MB; Shen JY; Cao Y; Xiong Y; Liu Y; Rayatpisheh S; Kang GC; Greisler HP
    J Biomed Mater Res A; 2009 Mar; 88(4):1104-21. PubMed ID: 19097157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-engineered Vascular Grafts in Children With Congenital Heart Disease: Intermediate Term Follow-up.
    Sugiura T; Matsumura G; Miyamoto S; Miyachi H; Breuer CK; Shinoka T
    Semin Thorac Cardiovasc Surg; 2018; 30(2):175-179. PubMed ID: 29427773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The challenge of small diameter vascular grafts.
    Burkel WE
    Med Prog Technol; 1988-1989; 14(3-4):165-75. PubMed ID: 2978590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts.
    Stekelenburg M; Rutten MC; Snoeckx LH; Baaijens FP
    Tissue Eng Part A; 2009 May; 15(5):1081-9. PubMed ID: 18831688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy in tissue-engineered blood vessels.
    Fields RC; Solan A; McDonagh KT; Niklason LE; Lawson JH
    Tissue Eng; 2003 Dec; 9(6):1281-7. PubMed ID: 14670116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Readily available tissue-engineered vascular grafts.
    Dahl SL; Kypson AP; Lawson JH; Blum JL; Strader JT; Li Y; Manson RJ; Tente WE; DiBernardo L; Hensley MT; Carter R; Williams TP; Prichard HL; Dey MS; Begelman KG; Niklason LE
    Sci Transl Med; 2011 Feb; 3(68):68ra9. PubMed ID: 21289273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of Vascular Graft Studies in Large Animal Models.
    Liu RH; Ong CS; Fukunishi T; Ong K; Hibino N
    Tissue Eng Part B Rev; 2018 Apr; 24(2):133-143. PubMed ID: 28978267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New prostheses for use in bypass grafts with special emphasis on polyurethanes.
    Tiwari A; Salacinski H; Seifalian AM; Hamilton G
    Cardiovasc Surg; 2002 Jun; 10(3):191-7. PubMed ID: 12044423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models for vascular tissue-engineering.
    Swartz DD; Andreadis ST
    Curr Opin Biotechnol; 2013 Oct; 24(5):916-25. PubMed ID: 23769861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts.
    Nottelet B; Pektok E; Mandracchia D; Tille JC; Walpoth B; Gurny R; Möller M
    J Biomed Mater Res A; 2009 Jun; 89(4):865-75. PubMed ID: 18465817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in tissue engineering for blood vessels.
    Nemeno-Guanzon JG; Lee S; Berg JR; Jo YH; Yeo JE; Nam BM; Koh YG; Lee JI
    J Biomed Biotechnol; 2012; 2012():956345. PubMed ID: 23251085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vascular prostheses: 50 years of advancement from synthetic towards tissue engineering and cell therapy].
    Chlupác J; Filová E; Bacáková L
    Rozhl Chir; 2010 Jan; 89(1):85-94. PubMed ID: 21351411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of tissue engineered vascular grafts: from research to clinical practice.
    McAllister T
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():3589. PubMed ID: 21096836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue engineered vascular grafts--preclinical aspects.
    Thomas LV; Lekshmi V ; Nair PD
    Int J Cardiol; 2013 Aug; 167(4):1091-100. PubMed ID: 23040078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue engineering of blood vessels in cardiovascular disease: moving towards clinical translation.
    Udelsman BV; Maxfield MW; Breuer CK
    Heart; 2013 Apr; 99(7):454-60. PubMed ID: 23363931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Heart and Great Vessels.
    Onwuka E; King N; Heuer E; Breuer C
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28289246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular engineering for bypass surgery.
    Daly CD; Campbell GR; Walker PJ; Campbell JH
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):659-65. PubMed ID: 16076276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue engineering therapy for cardiovascular disease.
    Nugent HM; Edelman ER
    Circ Res; 2003 May; 92(10):1068-78. PubMed ID: 12775655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.